Febuxostat given right away versus later for gout flare
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This Phase 3 study compares starting febuxostat immediately during a gout flare versus delaying the start. It aims to see which timing helps control gout better and safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- Your gout flare must be new or diagnosed within the last 5 days
- The flare must be in a peripheral joint (like a toe, foot, ankle, knee, or hand)
- Your blood uric acid level must be high enough (uricemia ≥ 420 micromol/L), even if you take a “water pill” (diuretic)
- Your kidneys must work enough (creatinine clearance at least 30 mL/min)
- You must be able to read, understand the study info, and sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This study tests whether starting a new gout medicine called dotinurad at different times after a flare begins can help the flare go away faster. It may help people who have frequent gout attacks or certain health conditions.
This trial tests whether the weight-loss drug orlistat, along with weight management, helps lower uric acid levels in people who have both gout and obesity. If you qualify, you may receive orlistat or a placebo to see if it reduces gout flare-ups and improves your uric acid control.
This study tests whether a pharmacist can help veterans with gout manage their uric acid levels using standard medications, aiming to reduce gout flares. If you've had a gout flare recently and are starting or already taking uric acid-lowering medicine, this might be a good fit.
This trial tests a new drug called dotinurad for gout patients whose standard medications either don't work or cause side effects. Dotinurad works differently by helping your body get rid of uric acid (the substance that causes gout attacks), and the study will see if it safely lowers uric acid levels.
Hear when a new Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.